603387 Stock Overview
Researches, develops, produces, and sells in vitro diagnostic reagents and instruments in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Getein Biotech, Inc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥8.79 |
| 52 Week High | CN¥12.11 |
| 52 Week Low | CN¥6.93 |
| Beta | 0.22 |
| 11 Month Change | 3.78% |
| 3 Month Change | 17.83% |
| 1 Year Change | -25.26% |
| 33 Year Change | -40.61% |
| 5 Year Change | -23.46% |
| Change since IPO | 5.39% |
Recent News & Updates
Is Getein Biotech (SHSE:603387) A Risky Investment?
Oct 03
Getein Biotech's (SHSE:603387) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Sep 10Shareholder Returns
| 603387 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | 3.3% | -2.6% | -2.1% |
| 1Y | -25.3% | -20.9% | 2.8% |
Return vs Industry: 603387 underperformed the CN Biotechs industry which returned -20.9% over the past year.
Return vs Market: 603387 underperformed the CN Market which returned 2.8% over the past year.
Price Volatility
| 603387 volatility | |
|---|---|
| 603387 Average Weekly Movement | 5.9% |
| Biotechs Industry Average Movement | 9.0% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 603387 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 603387's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 2,508 | n/a | www.getein.com.cn |
Getein Biotech, Inc researches, develops, produces, and sells in vitro diagnostic reagents and instruments in China and internationally. The company provides point-of-care detection of cardiac troponin I, chemiluminescence, biochemical detection, molecular detection, thrombus and hemostasis detection, blood cell analysis detection, urine analysis, quality control products, diagnostic raw materials, biochemical immunity, thrombosis and hemostasis, and other technical fields, covering cardiovascular, inflammation, kidney, thyroid function, hormone, glucose metabolism, tumor, blood cells, blood coagulation, and other detection fields. Its product applications include laboratory departments of medical institutions, emergency rooms, health examination center, community clinic, family personal health management, etc. The company was founded in 2002 and is headquartered in Nanjing, China.
Getein Biotech, Inc Fundamentals Summary
| 603387 fundamental statistics | |
|---|---|
| Market cap | CN¥4.46b |
| Earnings (TTM) | CN¥252.99m |
| Revenue (TTM) | CN¥1.25b |
17.6x
P/E Ratio3.6x
P/S RatioIs 603387 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603387 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.25b |
| Cost of Revenue | CN¥397.79m |
| Gross Profit | CN¥850.23m |
| Other Expenses | CN¥597.25m |
| Earnings | CN¥252.99m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.50 |
| Gross Margin | 68.13% |
| Net Profit Margin | 20.27% |
| Debt/Equity Ratio | 25.3% |
How did 603387 perform over the long term?
See historical performance and comparison